Site Members can sign up for company wide alerts
Lawsuit Overview
January 07, 2025 - An investor in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Regeneron Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between November 2, 2023 and October 30, 2024. Tarrytow...
You must register (for free) or login to view the entire case.